← Back to AstraZeneca Pharma India Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ASTRAZENPharmaceuticals

AstraZeneca Pharma India Ltd — Financial Ratios & Key Metrics

₹7931.00

-5.75%

P/E Ratio97.79xIndustry: 31.77x

ROE23.63%Return on equity

ROCE33.40%Return on capital

Debt/Equity0.04Low debt

💎

Valuation & Profitability

P/E Ratio

97.79x

Industry Average P/E

31.77x

Dividend Yield

0.35%

Market Cap

₹22.61K (Cr)

Sales Growth 5Y

15.59%

Profit Growth 5Y

19.45%

EPS Growth 5Y

19.45%

OPM 5Y Avg

14.65%

📉

Price Returns

1 Month

-5.11%

3 Months

+1.57%

6 Months

-4.50%

1 Year

+38.12%

52W Low

₹7201

Current

₹7931

52W High

₹10691

21% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹8585

▼ Price below SMA 50 — Bearish

SMA 200

₹8924

▼ Long-term downtrend

Volume Signal

784% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on AstraZeneca Pharma India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.